Item Type | Name |
Concept
|
Administration, Oral
|
Concept
|
Aged
|
Concept
|
Aged, 80 and over
|
Concept
|
Anticoagulants
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
Concept
|
Antineoplastic Agents, Phytogenic
|
Concept
|
Anal Canal
|
Concept
|
Benzimidazoles
|
Concept
|
Uterine Cervical Neoplasms
|
Concept
|
Chromatography, High Pressure Liquid
|
Concept
|
Combined Modality Therapy
|
Concept
|
Constipation
|
Concept
|
Electrophoresis, Agar Gel
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
Concept
|
Follow-Up Studies
|
Concept
|
Histocytochemistry
|
Concept
|
Humans
|
Concept
|
Immunohistochemistry
|
Concept
|
Indazoles
|
Concept
|
Indoles
|
Concept
|
Middle Aged
|
Concept
|
Ovariectomy
|
Concept
|
Ovary
|
Concept
|
Prospective Studies
|
Concept
|
Pyrroles
|
Concept
|
Rectum
|
Concept
|
Retrospective Studies
|
Concept
|
Thrombelastography
|
Concept
|
United States
|
Concept
|
Cohort Studies
|
Concept
|
Case-Control Studies
|
Concept
|
Tumor Suppressor Protein p53
|
Concept
|
Chemotherapy, Adjuvant
|
Concept
|
Health Care Costs
|
Concept
|
CA-125 Antigen
|
Concept
|
Microsatellite Repeats
|
Concept
|
DNA Methylation
|
Concept
|
BRCA1 Protein
|
Concept
|
Genes, BRCA1
|
Concept
|
Topotecan
|
Concept
|
Neoadjuvant Therapy
|
Concept
|
Angiogenesis Inhibitors
|
Concept
|
Genes, BRCA2
|
Concept
|
DNA Mismatch Repair
|
Concept
|
Young Adult
|
Concept
|
Chemoradiotherapy
|
Concept
|
Recombinational DNA Repair
|
Concept
|
Antibodies, Monoclonal, Humanized
|
Concept
|
Hereditary Breast and Ovarian Cancer Syndrome
|
Academic Article
|
A phase 2 evaluation of irofulven as second-line treatment of recurrent or persistent intermediately platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group trial.
|
Academic Article
|
Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
|
Academic Article
|
A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study.
|
Academic Article
|
Disparities Among Cervical Cancer Patients Receiving Brachytherapy.
|
Concept
|
Poly(ADP-ribose) Polymerase Inhibitors
|
Concept
|
Cytoreduction Surgical Procedures
|
Concept
|
Microbiota
|
Academic Article
|
Ovarian mixed germ cell tumor with predominance of polyembryoma: a case report with literature review.
|
Academic Article
|
Anorectal dysfunction after surgical treatment for cervical cancer.
|
Academic Article
|
Phase II evaluation of 3-day topotecan with cyclophosphamide in the treatment of recurrent ovarian cancer.
|
Academic Article
|
Failure of BRCA1 dysfunction to alter ovarian cancer survival.
|
Academic Article
|
A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer.
|
Academic Article
|
Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500.
|
Academic Article
|
A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study.
|
Academic Article
|
A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group Study (GOG 146Q).
|
Academic Article
|
We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies.
|
Academic Article
|
Since surgery isn't getting any easier, why is reimbursement going down? An update from the SGO taskforce on coding and reimbursement.
|
Academic Article
|
Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: results of a phase II trial.
|
Academic Article
|
Surgery in Advanced Ovary Cancer: Primary versus Interval Cytoreduction.
|
Academic Article
|
A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: a gynecologic oncology group study.
|
Academic Article
|
Implementation of an abdominal closure bundle to reduce surgical site infection in patients on a gynecologic oncology service undergoing exploratory laparotomy.
|
Academic Article
|
In vitro chemoresponse in metachronous pairs of ovarian cancers.
|
Academic Article
|
American College of Surgeons Clinical Congress 2016.
|
Academic Article
|
Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study.
|
Academic Article
|
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
|
Academic Article
|
Changes to outpatient evaluation and management coding: 2021 will be a better year.
|
Academic Article
|
The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes.
|
Academic Article
|
SGO Health Policy and Socioeconomic Committee: Current and Future Efforts of the Coding and Reimbursement Taskforce and the Policy, Quality and Outcomes Taskforce.
|
Academic Article
|
Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study.
|
Academic Article
|
Implementation of an enhanced recovery protocol in gynecologic oncology.
|
Academic Article
|
Fighting for a Fair Day's Wage.
|
Academic Article
|
A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study.
|
Academic Article
|
Primary Pelvic Papillary Thyroid Carcinoma with Metastases to Peritoneal Surfaces.
|
Academic Article
|
A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D.
|
Academic Article
|
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254).
|
Academic Article
|
Doubling down on the future of gynecologic oncology: The SGO future of the profession summit report.
|
Academic Article
|
Juvenile granulosa cell tumor in an adult woman during pregnancy: A case report and review of the literature.
|
Academic Article
|
A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.
|
Academic Article
|
Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study.
|
Academic Article
|
An SGO commentary: U.S. News and World Report gynecologic oncology procedural ratings-Do they reflect high-quality care?
|
Academic Article
|
A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer".
|
Academic Article
|
Vaginal lacerations during laparoscopic hysterectomy for endometrial cancer and local recurrence risk.
|
Academic Article
|
Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).
|
Academic Article
|
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma.
|
Academic Article
|
The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.
|
Academic Article
|
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258.
|
Academic Article
|
Reproductive sequelae of cancer treatment.
|
Academic Article
|
The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma.
|
Academic Article
|
Measurement of vaginal length: Reliability of the vaginal sound--a Gynecologic Oncology Group study.
|
Academic Article
|
p53 Mutations and microsatellite instability in ovarian cancer: Yin and yang.
|
Academic Article
|
Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy.
|
Academic Article
|
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
|
Academic Article
|
The glutathione S-transferase M1 genotype in ovarian cancer.
|